Tag Archives: cervical cancer

Doubts raised about effectiveness of HPV vaccines (Medical Journal)

Search for ‘gardasil’ in categories here (left of page) to find other articles on Gardasil. There are many that give injuries and deaths for this vaccine … EWR

From eurekalert.org

A new analysis of the clinical trials of HPV vaccines to prevent cervical cancer raises doubts about the vaccines’ effectiveness. The analysis, published by the Journal of the Royal Society of Medicine, assessed 12 published Phase 2 and 3 randomised controlled efficacy trials of the HPV vaccines Cervarix and Gardasil.

The analysis, carried out by researchers at Newcastle University and Queen Mary University of London, revealed many methodological problems in the design of the Phase 2 and 3 efficacy trials, leading to uncertainty regarding understanding the effectiveness of HPV vaccination.

The researchers found that the trials were not designed to detect cervical cancer, which takes decades to develop. Women in the trials were followed up for six years or less, apart from one trial extension to just under nine years. While the researchers found evidence that vaccination prevents low grade abnormal cell changes, they said this is not clinically important because no treatment is given.

Lead researcher Dr Claire Rees, of Queen Mary University of London, said: “Trials may have overestimated efficacy by combining high-grade cervical disease with low-grade cervical changes that occur more frequently but often resolve spontaneously without progressing. We found insufficient data to clearly conclude that HPV vaccine prevents the higher-grade abnormal cell changes that can eventually develop into cervical cancer.”

Dr Rees added: “Abnormal cell changes are likely to have been overdiagnosed in the trials because cervical cytology was conducted at 6-12 months rather than at the normal screening interval of 36 months. This, too, means that the trials may have overestimated the efficacy of the vaccine, again because some of the lesions would have regressed spontaneously.”

The researchers also found that the trial populations had limited relevance and validity for real world settings. The women in the trials were older than the target population.

Calling for women to still attend regular cervical screening, co-author of the study, Professor Allyson Pollock, of Newcastle University, said: “We have good evidence that cervical screening significantly reduces the risk of cervical cancer in women regardless of whether they have been vaccinated.”

https://www.eurekalert.org/pub_releases/2020-01/s-dra012120.php?fbclid=IwAR31FdTcv0lDCbkwUq_QAM2CTsNh7waF0TK_WbwdqJidIJiM4At4COfMoXU

Paradoxical Effect of Anti-HPV Vaccine Gardasil on Cervical Cancer Rate

Posted on:

Wednesday, February 6th 2019 at 12:30 pm

Written By:

Nicole Delépine

Originally published on www.docteur.nicoledelepine.fr

“How wonderful that we have met with a paradox. Now we have some hope of making progress”. Niels Bohr (Nobel prized for his works on the structure of the atom and chemical reactions)

Changing the natural history of cancer that increases in frequency and occurs faster.

It takes a long time to affirm that a preventive action really protects. But the failure of this supposed protection can sometimes be very quickly obvious. To prove that the Titanic was truly unsinkable would have required decades of navigation on the most dangerous seas of the world. Demonstrating that it wasn’t, took only a few hours … This » Titanic » demonstration is unfortunately reproduced by the Gardasil vaccination.

Evidence that vaccination increases the risk of invasive cancer can be rapid, if the vaccine changes the natural history of cancer by accelerating it. The analysis of trends in the incidence of invasive cervical cancer published in official statistics (registers) was studied in the first and most fully vaccinated countries (Australia, Great Britain, Sweden and Norway). Unfortunately, it’s the case for HPV vaccines.

Pre-vaccination period: spectacular success of cervical smear screening with a steady decrease in the rate of invasive cervical cancer.

In all countries that performed smear screening, the pre-vaccination period from 1989 to 2007 was marked by a significant decrease in the standardized incidence of cervical cancer.

In less than 20 years, the incidence of invasive cancer of the cervix decreased from:

  • 13.5 to 9.4 in Great Britain [1]
  • 13.5 to 7 in Australia [2]
  • 11.6 to 10.2 in Sweden [3]
  • 15.1 to 11 in Norway [4]
  • 10.7 to 6.67 in the USA [5]
  • 11 to 7.1 in France

Globally, in the countries that used smear screening, the average annual rate of decline was 2.5% between 1989 and 2000 and 1% between 2000 and 2007, resulting in a total decrease of nearly 30% across 1989-2007.

Era of vaccination: reversal of the trend. Gardasil’s prevention failure erases the beneficial effects of the smear and accelerates the onset of cervical cancer.

Since vaccination, in all the countries implemented with a large vaccination program, there is a reversal of the trend, with a significant increase in the frequency of invasive cancers in the most vaccinated groups. Let’s look at OFFICIAL sources.

AUSTRALIA: contrary to the FAKE NEWS OF THE MEDIA AND POLITICS, REGISTER DOES NOT SHOW CANCERS OF THE CERVIX DISAPPEAR, BUT INCREASE.

Australia was the first country to organize routine immunization for girls (April 2007 school-based program for females aged 12–13 years, July 2007 time-limited catch-up program targeting females aged 14–26 years) and then for boys (2013). According to the last Australian Institute of Health and Welfare publication (2018 publication describing the detailed rates until 2014) [6], the standardized incidence in the overall population has not decreased since vaccination 7/100000 in 2007 versus 7.4 in 2014.

This global stabilization results from two contradictory trends that only appear by examining trends, according to age groups.

Vaccinated age groups women have seen their risk increase:

100% increase for those aged 15 to 19 (from 0.1 in 2007 to 0.2 in 2014)

113% increase (from 0.7 to 1.5) in groups aged 20 to 24 more than 80% of them were catch up vaccinated when 13 to 17 years old.

But, as the figures are very small, this increase does not reach statistical significance.

About a third increase for 25-29 group (from 5.9 to 8,p=0.06) and for 30-34 (from 9.9 to 12.4 c=0.80 p=0.01) less vaccinated. These increases are statistically significant cannot be due to hazard.

A drama known to one top athlete: Sarah Tait

This increased risk of cancer following vaccination was dramatically illustrated by the sad story of Sarah Tait, olympic rowing champion, at the 2012 London Olympics. This champion saw her life shattered in full glory: she suffered invasive cervical cancer a few years later, being vaccinated and died at age 33. Of course, we don’t know if vaccination was the direct cause of her cancer, but she has, statistically, a one in two chances of having suffered from a cancer linked to vaccination (to be part of the 113% increase of cancer observed after vaccination). In addition, we remark that cancer appears very early in this woman.

Non vaccinated women continue to benefit from screening with pap smear

During the same period, older women (and therefore unvaccinated) saw their cancer risk decrease significantly:

  • less 17% for women aged 55 to 59 (from 9.7 to 8.1)
  • less 13% for women aged 60 to 64 ( from 10.3 to 8.9)
  • less 23% for those aged 75 to 79 (from 11.5 to 8.8)
  • and even less 31% for those aged 80 to 84 (from 14.5 to 10)

GREAT BRITAIN: THE PARADOXICAL EFFECT OF GARDASIL PROMOTING CANCER

In UK, a national program was introduced in 2008 to offer HPV vaccination routinely to 12–13-year-old and offer catch-up vaccination to girls up to 18 years old. The UK national program initially used the bivalent HPV vaccine (Cervarix), but, changed in 2012 to use the quadrivalent vaccine (Gardasil). HPV vaccination coverage in England has been high with over 80% of 12–13 years old receiving the full course coverage. The catch-up cohort has been lower covered (ranging from 39% to 76%).

Since the vaccination, the standardized incidence in the overall population increased from 9.4 per 100000 in 2007 to 9.6 in 2015. We observe contrasting trends between the age groups.

Vaccination promoters expected cervical cancer rates decrease in women aged 20 to 24 from 2014, as vaccinated adolescents enter their second decade. However, in 2016, national statistics showed a sharp and significant increase in the rate of cervical cancer in this age group. This information of 2016 has unfortunately not been publicized. They could have served as an alert.

Women aged between 20 and 25 yearsvaccinated for more than 85% of them, when they were between 14 and 18 years old, have seen their cancer risk increase by 70% in 2 years (from 2.7 in 2012 to 4.6 per 100,000 in 2014 p = 0.0006) and those aged 25 to 30, ( aged between 18 and 23 at the time of the vaccination campaign) have seen their cancer risk increase by 100% between 2007 and 2015 [7] (from 11 / 100,000 to 22 / 100,000 ).

Women 25 to 34 years, (less vaccinated, only exposed to some catch-up vaccinations), have seen their risk increased by 18% (from 17 in 2007 to 20 in 2014).

In Great Britain, as in Australia, older, unvaccinated women have seen their risk decrease:

(-13% for women aged 65 to 79 and -10% for those over 80), most likely because continuation of smear screening.

SAME PARADOXICAL PHENOMENON OF GARDASIL IN SWEDEN: THE RATE OF CANCER INCREASES IN THE VACCINATED AGE GROUPS. ALERT!

In Sweden, Gardasil has been used since 2006. The vaccination program was rolled out in 2010, with vaccination coverage of 12-year-old girls approaching 80%. In 2012-2013, with a catch-up program, almost all girls aged 13 to 18 were vaccinated.

In this country, the standardized incidence of cervical cancer in the global population has increased steadily since vaccination from 9.6 per 100000 in 2006 to 9.7 in 2009, 10.3 in 2012 and 11.49 in 2015 [8]. This increase is mostly due to the increase in the incidence of invasive cancers among women aged 20-24 whose incidence doubled (from 1.86 in 2007 to3.72 in 2015 p<0.001) [9] and in women aged 20 to 29 the incidence of invasive cancer of the cervix increased by 19% (from 6.69 to 8.01)

In contrast, as in Australia and Great Britain, a decrease in the incidence of invasive cancer has been observed in women over 50, a group that has not been included in the vaccination program. The incidence of invasive cancer of the cervix decreased between 2007 and 2015 by 6% for women aged 50 to 59 (from 14.24 to 13.34), and 4% for those aged 60 to 69 (12.63%). at 12.04,) 17% for those aged 70 to 79 (from 15.28 to 12.66) and 12% for those over 80 (from 15.6 to 13.68).

IN NORWAY

Cancer registry shows an increase in the standardized incidence of invasive cancer of the cervix from 11.7 in 2007 to 12.2 in 2009, 13.2 in 2012 and 14. 9 2015 [10].

This increase is due -almost exclusively- to young women, which include all vaccinated, as evidenced by the sharp decline of the average age of onset of the cervix cancer from 48 years in 2002-2006 to 45 years in 2012-2016.

Between 2007 and 2015, the incidence of invasive cervical cancer increased by 8% among women aged 20 to 29 (from 7.78 to 8.47). [11]

During the same period, a decrease in the incidence of invasive cancer was observed in older women, not involved in the vaccination program: -11% for women aged 55 to 64 (15.47 to 13.7), -16% for those aged 65 to 74 (17.7 to 14.71) and -29% for those aged 75 to 85 (18.39 to 13).

IN USA

In this country, vaccination coverage is lower than in previous countries (close to 60%).

According to the Cancer Statistics Review 1975-2015 [12], the standardized incidence of invasive cervical cancer remains stable (+0.1) since vaccination.

In US, the same discrepancy is observed according to age groups, but of lesser amplitude. Women over 50, benefit a 5% decrease in their risk (from 10.37 per 100000 in 2007 to 9.87 in 2015), whereas younger women, which include vaccinated, have given their risk increase of 4% (5.24 in 2007 to 5.47 in 2015).

WITNESS COUNTRY: FRANCE 

The evolution of these countries, with high immunization coverage, can be compared to the trend observed in metropolitan France, where HPV vaccination coverage is very low (around 15%). France can be considered, for this reason, as a control country. In France [13] the incidence of cervical cancer has steadily decreased from 15 in 1995 to 7.5 in 2007, 6.7 in 2012 and 6 in 2017, much lower than those of countries with high vaccine coverage.

This decrease in incidence was accompanied by a decrease in mortality from 5 in 1980 to 1.8 in 2012 and 1.7 in 2017.

It is paradoxical and very worrying that these excellent French results, with low cervix cancer rate and low related mortality, could be jeopardized by an obligation considered in the short term by our policies, for some misinformed and other big pharma links [14].

DRAMATIC AND UNEXPECTED PARADOXICAL EFFECT OF GARDASIL: THE ALERT MUST BE GIVEN TO DECISION MAKERS AND THE MEDIA. 

In all countries that achieved high HPV vaccination coverage, official cancer registries show an increase in the incidence of invasive cervical cancer.

For women under 20, the crude numbers are too small to reach statistical significance, but the similar increases in all the studied countries constitutes a strong alarm signal.

For women 20-30 the incidence increases after catch up vaccination, and is highly significant (p<0.01or 0.001). In these same countries, during the same period, older women, not vaccinated, have seen their risk of cervical cancer continue to decline.

Similarly, in metropolitan France, a country with low vaccination coverage, the incidence of cervical cancer continues to decline at a rate comparable to the pre-vaccination period.

These paradoxical results plea for a rapid revision of recommendations and intensive research to explain this catastrophic issue.

For additional research on the health risks of the HPV vaccine, visit the GreenMedInfo database on the subject. 


References

[1] Cancer Research UK, Cervical Cancer (C53): 1993-2015, European Age-Standardized Incidence Rates per 100,000 Population, Females, UK Accessed 08 [ 2018 ].

[2] AIHW [2]. 13. AIHW 2017. Cancer in Australia 2017. Cancer series no. 101. Cat. No. CAN 100. Canberra: AIHW.

[3] NORDCAN, Association of the Nordic Cancer Registries 3.1.2018

[4] Bo T Hansen, Suzanne Campbell, Mari Nygård Long-term incidence of HPV related cancers, and cases preventableby HPV vaccination: a registry-based study in Norway BMJ Open 2018; 8: e019005

[5] Table 5.1 Cancer of the Cervix Uteri (Invasive) Trends in SEER Incidence and US Mortality SEER Cancer Statistics Review 1975-2012

[6] Australian Institute of Health and Welfare (AIHW) 2017 Australian Cancer Incidence and Mortality (ACIM) books: cervical cancer Canberra: AIHW. <https://www.aihw.gov.au/acim-books>.

[7] A Castanona, P Sasienia Is the recent increase in cervical cancer in women aged 20-24 years in England a cause for concern? Preventive Medicine 107 (2018) 21-28

[8] Nationellt Kvalitetsregister für Cervix cancer prevention (NKCx), https://nkcx.se/templates/_rsrapport_2017.pdf [in Swedish]

[9] Engholm G, Ferlay J, Christensen N, Hansen HL, Hertzum-Larsen R, Johannesen TB, Kejs AMT, Khan S, Olafsdottir E, Petersen T, Schmidt LKH, Virtanen A and Storm HH: Cancer Incidence, Mortality, Prevalence and Survival in the Nordic Countries, Version 8.1 (28.06.2018). Association of the Nordic Cancer Registries. Danish Cancer Society. Available from https://www.ancr.nu, accessed it 30 / 09 / 2018.

[10] Cancer in Norway 2016

[11] Engholm G, Ferlay J, Christensen N, Hansen HL, Hertzum-Larsen R, Johannesen TB, Kejs AMT, Khan S, Olafsdottir E, Petersen T, Schmidt LKH, Virtanen A and Storm HH: Cancer Incidence, Mortality, Prevalence and Survival in the Nordic Countries, Version 8.1 (28.06.2018). Association of the Nordic Cancer Registries. Danish Cancer Society. Available from https://www.ancr.nu, accessed is 1 / 10 / 2018

[12] SEER 9 National Center for Health Statistics, CDC

[13] Francim, HCL, Public Health France, INCa. Projections of Cancer Incidence and Mortality in Metropolitan France in 2017 – Solid Tumors [Internet]. Saint-Maurice: Public health France [updated 02/01/2018; viewed on the 09/05/2018

[14] https://www.agoravox.fr/tribune-libre/article/gardasil-alerte-risque-imminent-d-206314 Gardasil, alert, imminent risk of mandatory vaccination against HPV unnecessary, and sometimes dangerous, for girls and boys.

Disclaimer: This article is not intended to provide medical advice, diagnosis or treatment. Views expressed here do not necessarily reflect those of GreenMedInfo or its staff.
SOURCE
HPV

http://www.greenmedinfo.com/blog/paradoxical-effect-anti-hpv-vaccine-gardasil-cervical-cancer-rate

Studies indicate countries with high HPV vaccination coverage show increased incidence of invasive cervical cancer

Paradoxical Effect of Anti-HPV Vaccine Gardasil on Cervical Cancer Rate

Posted on:

Wednesday, February 6th 2019 at 12:30 pm

Written By:

Nicole Delépine


Originally published on www.docteur.nicoledelepine.fr

“How wonderful that we have met with a paradox. Now we have some hope of making progress”. Niels Bohr (Nobel prized for his works on the structure of the atom and chemical reactions)

Changing the natural history of cancer that increases in frequency and occurs faster.

It takes a long time to affirm that a preventive action really protects. But the failure of this supposed protection can sometimes be very quickly obvious. To prove that the Titanic was truly unsinkable would have required decades of navigation on the most dangerous seas of the world. Demonstrating that it wasn’t, took only a few hours … This » Titanic » demonstration is unfortunately reproduced by the Gardasil vaccination.

Evidence that vaccination increases the risk of invasive cancer can be rapid, if the vaccine changes the natural history of cancer by accelerating it. The analysis of trends in the incidence of invasive cervical cancer published in official statistics (registers) was studied in the first and most fully vaccinated countries (Australia, Great Britain, Sweden and Norway). Unfortunately, it’s the case for HPV vaccines.

Pre-vaccination period: spectacular success of cervical smear screening with a steady decrease in the rate of invasive cervical cancer.

In all countries that performed smear screening, the pre-vaccination period from 1989 to 2007 was marked by a significant decrease in the standardized incidence of cervical cancer.

In less than 20 years, the incidence of invasive cancer of the cervix decreased from:

  • 13.5 to 9.4 in Great Britain [1]
  • 13.5 to 7 in Australia [2]
  • 11.6 to 10.2 in Sweden [3]
  • 15.1 to 11 in Norway [4]
  • 10.7 to 6.67 in the USA [5]
  • 11 to 7.1 in France

Globally, in the countries that used smear screening, the average annual rate of decline was 2.5% between 1989 and 2000 and 1% between 2000 and 2007, resulting in a total decrease of nearly 30% across 1989-2007.

Era of vaccination: reversal of the trend. Gardasil’s prevention failure erases the beneficial effects of the smear and accelerates the onset of cervical cancer. 

Since vaccination, in all the countries implemented with a large vaccination program, there is a reversal of the trend, with a significant increase in the frequency of invasive cancers in the most vaccinated groups. Let’s look at OFFICIAL sources.

AUSTRALIA: contrary to the FAKE NEWS OF THE MEDIA AND POLITICS, REGISTER DOES NOT SHOW CANCERS OF THE CERVIX DISAPPEAR, BUT INCREASE.

Australia was the first country to organize routine immunization for girls (April 2007 school-based program for females aged 12–13 years, July 2007 time-limited catch-up program targeting females aged 14–26 years) and then for boys (2013). According to the last Australian Institute of Health and Welfare publication (2018 publication describing the detailed rates until 2014) [6], the standardized incidence in the overall population has not decreased since vaccination 7/100000 in 2007 versus 7.4 in 2014.

This global stabilization results from two contradictory trends that only appear by examining trends, according to age groups.

Vaccinated age groups women have seen their risk increase:

100% increase for those aged 15 to 19 (from 0.1 in 2007 to 0.2 in 2014)

113% increase (from 0.7 to 1.5) in groups aged 20 to 24 more than 80% of them were catch up vaccinated when 13 to 17 years old.

But, as the figures are very small, this increase does not reach statistical significance.

About a third increase for 25-29 group (from 5.9 to 8,p=0.06) and for 30-34 (from 9.9 to 12.4 c=0.80 p=0.01) less vaccinated. These increases are statistically significant cannot be due to hazard.

A drama known to one top athlete: Sarah Tait

This increased risk of cancer following vaccination was dramatically illustrated by the sad story of Sarah Tait, olympic rowing champion, at the 2012 London Olympics. This champion saw her life shattered in full glory: she suffered invasive cervical cancer a few years later, being vaccinated and died at age 33. Of course, we don’t know if vaccination was the direct cause of her cancer, but she has, statistically, a one in two chances of having suffered from a cancer linked to vaccination (to be part of the 113% increase of cancer observed after vaccination). In addition, we remark that cancer appears very early in this woman.

Non vaccinated women continue to benefit from screening with pap smear

During the same period, older women (and therefore unvaccinated) saw their cancer risk decrease significantly:

  • less 17% for women aged 55 to 59 (from 9.7 to 8.1)
  • less 13% for women aged 60 to 64 ( from 10.3 to 8.9)
  • less 23% for those aged 75 to 79 (from 11.5 to 8.8)
  • and even less 31% for those aged 80 to 84 (from 14.5 to 10)

GREAT BRITAIN: THE PARADOXICAL EFFECT OF GARDASIL PROMOTING CANCER

In UK, a national program was introduced in 2008 to offer HPV vaccination routinely to 12–13-year-old and offer catch-up vaccination to girls up to 18 years old. The UK national program initially used the bivalent HPV vaccine (Cervarix), but, changed in 2012 to use the quadrivalent vaccine (Gardasil). HPV vaccination coverage in England has been high with over 80% of 12–13 years old receiving the full course coverage. The catch-up cohort has been lower covered (ranging from 39% to 76%).

Since the vaccination, the standardized incidence in the overall population increased from 9.4 per 100000 in 2007 to 9.6 in 2015. We observe contrasting trends between the age groups.

Vaccination promoters expected cervical cancer rates decrease in women aged 20 to 24 from 2014, as vaccinated adolescents enter their second decade. However, in 2016, national statistics showed a sharp and significant increase in the rate of cervical cancer in this age group. This information of 2016 has unfortunately not been publicized. They could have served as an alert.

Women aged between 20 and 25 yearsvaccinated for more than 85% of them, when they were between 14 and 18 years old, have seen their cancer risk increase by 70% in 2 years (from 2.7 in 2012 to 4.6 per 100,000 in 2014 p = 0.0006) and those aged 25 to 30, ( aged between 18 and 23 at the time of the vaccination campaign) have seen their cancer risk increase by 100% between 2007 and 2015 [7] (from 11 / 100,000 to 22 / 100,000 ).

Women 25 to 34 years, (less vaccinated, only exposed to some catch-up vaccinations), have seen their risk increased by 18% (from 17 in 2007 to 20 in 2014).

In Great Britain, as in Australia, older, unvaccinated women have seen their risk decrease:

(-13% for women aged 65 to 79 and -10% for those over 80), most likely because continuation of smear screening.

SAME PARADOXICAL PHENOMENON OF GARDASIL IN SWEDEN: THE RATE OF CANCER INCREASES IN THE VACCINATED AGE GROUPS. ALERT!

In Sweden, Gardasil has been used since 2006. The vaccination program was rolled out in 2010, with vaccination coverage of 12-year-old girls approaching 80%. In 2012-2013, with a catch-up program, almost all girls aged 13 to 18 were vaccinated.

In this country, the standardized incidence of cervical cancer in the global population has increased steadily since vaccination from 9.6 per 100000 in 2006 to 9.7 in 2009, 10.3 in 2012 and 11.49 in 2015 [8]. This increase is mostly due to the increase in the incidence of invasive cancers among women aged 20-24 whose incidence doubled (from 1.86 in 2007 to3.72 in 2015 p<0.001) [9] and in women aged 20 to 29 the incidence of invasive cancer of the cervix increased by 19% (from 6.69 to 8.01)

In contrast, as in Australia and Great Britain, a decrease in the incidence of invasive cancer has been observed in women over 50, a group that has not been included in the vaccination program. The incidence of invasive cancer of the cervix decreased between 2007 and 2015 by 6% for women aged 50 to 59 (from 14.24 to 13.34), and 4% for those aged 60 to 69 (12.63%). at 12.04,) 17% for those aged 70 to 79 (from 15.28 to 12.66) and 12% for those over 80 (from 15.6 to 13.68).

IN NORWAY

Cancer registry shows an increase in the standardized incidence of invasive cancer of the cervix from 11.7 in 2007 to 12.2 in 2009, 13.2 in 2012 and 14. 9 2015 [10].

This increase is due -almost exclusively- to young women, which include all vaccinated, as evidenced by the sharp decline of the average age of onset of the cervix cancer from 48 years in 2002-2006 to 45 years in 2012-2016.

Between 2007 and 2015, the incidence of invasive cervical cancer increased by 8% among women aged 20 to 29 (from 7.78 to 8.47). [11]

During the same period, a decrease in the incidence of invasive cancer was observed in older women, not involved in the vaccination program: -11% for women aged 55 to 64 (15.47 to 13.7), -16% for those aged 65 to 74 (17.7 to 14.71) and -29% for those aged 75 to 85 (18.39 to 13).

IN USA

In this country, vaccination coverage is lower than in previous countries (close to 60%).

According to the Cancer Statistics Review 1975-2015 [12], the standardized incidence of invasive cervical cancer remains stable (+0.1) since vaccination.

In US, the same discrepancy is observed according to age groups, but of lesser amplitude. Women over 50, benefit a 5% decrease in their risk (from 10.37 per 100000 in 2007 to 9.87 in 2015), whereas younger women, which include vaccinated, have given their risk increase of 4% (5.24 in 2007 to 5.47 in 2015).

WITNESS COUNTRY: FRANCE 

The evolution of these countries, with high immunization coverage, can be compared to the trend observed in metropolitan France, where HPV vaccination coverage is very low (around 15%). France can be considered, for this reason, as a control country. In France [13] the incidence of cervical cancer has steadily decreased from 15 in 1995 to 7.5 in 2007, 6.7 in 2012 and 6 in 2017, much lower than those of countries with high vaccine coverage.

This decrease in incidence was accompanied by a decrease in mortality from 5 in 1980 to 1.8 in 2012 and 1.7 in 2017.

It is paradoxical and very worrying that these excellent French results, with low cervix cancer rate and low related mortality, could be jeopardized by an obligation considered in the short term by our policies, for some misinformed and other big pharma links [14].

DRAMATIC AND UNEXPECTED PARADOXICAL EFFECT OF GARDASIL: THE ALERT MUST BE GIVEN TO DECISION MAKERS AND THE MEDIA. 

In all countries that achieved high HPV vaccination coverage, official cancer registries show an increase in the incidence of invasive cervical cancer.

For women under 20, the crude numbers are too small to reach statistical significance, but the similar increases in all the studied countries constitutes a strong alarm signal.

For women 20-30 the incidence increases after catch up vaccination, and is highly significant (p<0.01or 0.001). In these same countries, during the same period, older women, not vaccinated, have seen their risk of cervical cancer continue to decline.

Similarly, in metropolitan France, a country with low vaccination coverage, the incidence of cervical cancer continues to decline at a rate comparable to the pre-vaccination period.

These paradoxical results plea for a rapid revision of recommendations and intensive research to explain this catastrophic issue.

For additional research on the health risks of the HPV vaccine, visit the GreenMedInfo database on the subject. 


References

[1] Cancer Research UK, Cervical Cancer (C53): 1993-2015, European Age-Standardized Incidence Rates per 100,000 Population, Females, UK Accessed 08 [ 2018 ].

[2] AIHW [2]. 13. AIHW 2017. Cancer in Australia 2017. Cancer series no. 101. Cat. No. CAN 100. Canberra: AIHW.

[3] NORDCAN, Association of the Nordic Cancer Registries 3.1.2018

[4] Bo T Hansen, Suzanne Campbell, Mari Nygård Long-term incidence of HPV related cancers, and cases preventableby HPV vaccination: a registry-based study in Norway BMJ Open 2018; 8: e019005

[5] Table 5.1 Cancer of the Cervix Uteri (Invasive) Trends in SEER Incidence and US Mortality SEER Cancer Statistics Review 1975-2012

[6] Australian Institute of Health and Welfare (AIHW) 2017 Australian Cancer Incidence and Mortality (ACIM) books: cervical cancer Canberra: AIHW. <Http://www.aihw.gov.au/acim-books>.

[7] A Castanona, P Sasienia Is the recent increase in cervical cancer in women aged 20-24 years in England a cause for concern? Preventive Medicine 107 (2018) 21-28

[8] Nationellt Kvalitetsregister für Cervix cancer prevention (NKCx), http://nkcx.se/templates/_rsrapport_2017.pdf [in Swedish]

[9] Engholm G, Ferlay J, Christensen N, Hansen HL, Hertzum-Larsen R, Johannesen TB, Kejs AMT, Khan S, Olafsdottir E, Petersen T, Schmidt LKH, Virtanen A and Storm HH: Cancer Incidence, Mortality, Prevalence and Survival in the Nordic Countries, Version 8.1 (28.06.2018). Association of the Nordic Cancer Registries. Danish Cancer Society. Available from http://www.ancr.nu, accessed it 30 / 09 / 2018.

[10] Cancer in Norway 2016

[11] Engholm G, Ferlay J, Christensen N, Hansen HL, Hertzum-Larsen R, Johannesen TB, Kejs AMT, Khan S, Olafsdottir E, Petersen T, Schmidt LKH, Virtanen A and Storm HH: Cancer Incidence, Mortality, Prevalence and Survival in the Nordic Countries, Version 8.1 (28.06.2018). Association of the Nordic Cancer Registries. Danish Cancer Society. Available from http://www.ancr.nu, accessed is 1 / 10 / 2018

[12] SEER 9 National Center for Health Statistics, CDC

[13] Francim, HCL, Public Health France, INCa. Projections of Cancer Incidence and Mortality in Metropolitan France in 2017 – Solid Tumors [Internet]. Saint-Maurice: Public health France [updated 02/01/2018; viewed on the 09/05/2018

[14] https://www.agoravox.fr/tribune-libre/article/gardasil-alerte-risque-imminent-d-206314 Gardasil, alert, imminent risk of mandatory vaccination against HPV unnecessary, and sometimes dangerous, for girls and boys.

Disclaimer: This article is not intended to provide medical advice, diagnosis or treatment. Views expressed here do not necessarily reflect those of GreenMedInfo or its staff.

http://www.greenmedinfo.com/blog/paradoxical-effect-anti-hpv-vaccine-gardasil-cervical-cancer-rate?

A research team identifies unknown contaminants in all but one of 30 human & veterinary vaccines

From thecontrail.com

WARNING about vaccines: Sophisticated new method of analysis reveal extensive contamination

The study was conducted by a husband and wife research team, Antonietta Gatti and Stefano Montanari. Antonietta Gatti, a selected expert of the World Health Organization (WHO) for the safety of nanotechnological food, is a member of the National Council of Research of Italy and the scientific director of Nanodiagnostics.

Using electron-microscopy, the researchers examined 44 samples of 30 different human and veterinary vaccines, including those for influenza, meningitis, allergies, cervical cancer and hepatitis.

And what they found was disturbing. The pair identified contaminants in all tested vaccines – but for one. (The lone vaccine to test free of inorganic contaminants was Feligen, produced for use on cats).
When it comes to vaccine safety, humans didn’t fare as well.

In the study, published in 2017 in International Journal of Vaccines and Vaccinations, the researchers reported that they found both single particles and aggregates – or assemblages – of a variety of bizarre and toxic substances in the vaccines.

Researchers “baffled” by the composition of the contaminants

The researchers described the contaminants as “micro- and nano-sized particulate matter composed of inorganic elements not declared in the products’ ingredients lists.”

https://thecontrail.com/forum/topics/bombshell-all-tested-vaccines-reveal-toxic-substances-linked-to-a

There have been no reports of any teen contracting cervical cancer from HPV ever – what you need to know about the Gardasil vaccine

Gardasil, the HPV (Human Papillomavirus) vaccine on the Centers for Disease Control and Prevention’s (CDC) list of recommended inoculations for teenagers, has been the subject of debate worldwide since it was fast-tracked for approval in the US in 2006. The Merck-manufactured drug was developed to prevent infections caused by HPV, which is a group of 150 related viruses — 15 of which are linked to cervical cancer. At the heart of the controversies are questions around the need for the vaccine, the GardasilGirl.jpgefficacy of the vaccine and the fast-growing number of reports of severe reactions to the vaccine. The latter question has moved to the forefront of the debate as safety testing concerns have been raised and the number of vaccine-injured children has grown.

Gardasil- A Case of Insufficient Testing?

Despite no recorded outbreak of cervical cancer nor change in sexual behavioral risks among teenagers, Gardasil vaccine was studied for less than two years prior to its approval. This was particularly curious since the cancer the vaccine purports to prevent does not present itself for 20-30 years.

And, while the drug was tested only on women aged 16-23 before it became the first licensed HPV vaccine in the United States, today it is recommended for boys and girls as young as 10 years old.

Moreover, Gardasil was not tested on people with health problems nor in combination with all the other vaccines routinely administered to American adolescents, such as Tdap and meningococcal vaccines.

Although the CDC claims that sufficient testing has been done, The National Vaccine Information Center discovered the opposite from independent research on the combination of Gardasil and Menactra (a meningococcal vaccine), if given on the same day. Respiratory problem reports increased by 114%, cardiac problems by 118%, neuromuscular and coordination problems by 234%, convulsions by 301%, and injuries caused by falls after unconsciousness shot up by 674%.

READ MORE

http://info.cmsri.org/the-driven-researcher-blog/what-you-need-to-know-about-gardasil

India tosses out Gates Foundation due to conflicts of interest with Big Pharma

Search our site for other articles featuring various little known truths about the Gates’. Bill would like to reduce the world’s population using vaccines. I thought these were supposed to save lives? If you watch the video at the link there, you can hear him speak on the topic. It’s definitely a little smoke and ‘mirrorish’, the rationale around how populations will decrease with vaccines. If you think I’m being conspiratorial, do the search as suggested & find the article telling us some of his shots were laced with ingredients that induce abortions. Nice plan Bill. I really do feel that these people who are advocating less folk on the planet (which is amply big enough for all) ought to show the way by expunging themselves first. They never do though. Like the British Royals, they pick first on the vulnerable nations like Africa.
This article is from Natural News…
(Natural News) In the U.S., many look to him as a benevolent humanitarian simply trying to save the world from communicable disease. But in India, billionaire software guru Bill Gates has basically been told to get the hell out the country now that he and his wife Melinda’s infamous foundation has been exposed as nothing more than a vaccine-pushing fraud directly tied to Big Pharma.

India’s National Technical Advisory Group on Immunization (NTAGI) announced recently that it is officially cutting ties with the Bill & Melinda Gates Foundation. This announcement comes after it was shown that so-called vaccine “campaigns” conducted on tens of thousands of young girls throughout India back in 2009-2010 that were meant to help protect them from cervical cancer were actually cloaked vaccine trials involving two highly controversial vaccines known to injure and kill.

The vaccines in question are Cervarix by GlaxoSmithKline (GSK) and Gardasil by Merck & Co., both of which are marketed as protecting against the human papillomavirus (HPV), which is claimed to have a link to cervical cancer. Both vaccines come with extreme side effects, and evidence shows that GSK and Merck essentially teamed up with the Gates Foundation to take advantage of young Indian girls and use them as human guinea pigs in trials of the two vaccines.

According to independent journalists, these trials resulted in thousands of injuries and hundreds of deaths that were eventually traced back to the two vaccines. Once news of this got back to Indian authorities, an investigation was launched that landed the Gates Foundation in court for serious ethical violations.

READ MORE

https://www.naturalnews.com/2017-02-14-india-tosses-out-gates-foundation-due-to-conflicts-of-interest-with-big-pharma.html

Photo: Wikipedia

College Student Gets HPV Cancer 18 Months After Receiving Gardasil Vaccine, then Declines Chemo & Heals Herself with Natural Means

Here is the incredible testimony of a young woman who against all odds survived the medical system that appears not only to have harmed her with a vaccine (the vaccine was followed by ongoing debilitating illness) but also to have caused her to contract life threatening cancer. This smart woman, having already lost several family members from cancer, then declines the standard offering of radiation and chemotherapy which only works 3% of the time, and did her own research on cures. She came up with the Gerson therapy and treated herself all the way to wellness, at her own expense. A must listen and clear proof of the miserable success rate the standard mainstream medical and pharmaceutical industry can offer you. We ought all to learn from this woman and follow suit. Learn further on how the medical industry was heisted in the early part of the twentieth century by wealthy people, resulting in the treatment of symptoms. A veritable cash cow. Our key to health is a strong immune system, not what is currently offered in the form of vaccines, pills and artificial chemicals. See our Cancer pages for further info and learn of other success stories, and watch the video here for the full story told by this brave young woman who has beaten the death sentence.

EnvirowatchRangitikei

VAXXED TV

Published on Jan 9, 2017

Erin was a completely healthy college student who was asked to take Gardasil as part of a trial. Within 24 hours she was violently sick, vomiting, and went on to develop Cervical cancer within 18 months, the very thing the vaccine was supposed to protect her from.

For further info:

http://vaccineimpact.com/2017/college-student-gets-hpv-cancer-after-receiving-gardasil-vaccine/


11752454_10153373161647931_8954523729785441791_n

RELATED:

http://www.vaccine-injury.info/gardasil.cfm

http://healthimpactnews.com/2015/tv2-denmark-documentary-on-hpv-vaccine-shows-lives-of-young-women-ruined/

http://www.organiclifestylemagazine.com/vaccines-retroviruses-dna-and-the-discovery-that-destroyed-judy-mikovits-career

https://vactruth.com/2012/05/13/gardasil-may-cause-cancer/

Chief HPV Scientist Admits Vaccines Are A Deadly Scam

HPV-vaccine-creator-speaks-out-700x350
A leading expert Dr Diane Harper speaks out on HPV vaccines

Dr. Diane Harper, one of the leading experts on HPV vaccines, has spoken out about the ‘deadly effects’ the vaccines have on those who take it. 

11752454_10153373161647931_8954523729785441791_n

Dr. Harper was responsible for the Phase II and Phase III safety and effectiveness studies for Gardasil and Cervarix, which secured approval for their use on the public.

“Dr. Harper explained in her presentation that the cervical cancer risk in the U.S. is already extremely low, and that vaccinations are unlikely to have any effect upon the rate of cervical cancer in the United States.”

During a speech at the 4th International Conference on Vaccination, she decided to come clean to the public about the dangers of receiving the HPV vaccine – saying that she could no longer sleep at night.

READ MORE

http://yournewswire.com/chief-hpv-scientist-admits-vaccines-are-a-deadly-scam/


For more info and links to docos see our Vaccine pages (remember the sub pages). Educate yourself and make informed decisions from all the data, not just what mainstream feed you. Over 35 years ago (I learned this only recently) one of our local country GPs did not vaccinate his own children. That tells you something. 

EnvirowatchRangitikei

1